Latest news
IPHA Looks 1053.3% Overvalued on GF Value™ - GuruFocusGuruFocus · Mon, 10 Aug 2026 10:26:01 GMTAVAV Looks 28.8% Undervalued on GF Value™ Amid $400M Anti-Drone Laser Deal - GuruFocusGuruFocus · Sat, 08 Aug 2026 03:58:52 GMTAVAV Looks 28.8% Undervalued on GF Value™ After $400M Anti-Drone Contract - GuruFocusGuruFocus · Sat, 08 Aug 2026 03:23:59 GMTWedbush Upgrades Replimune (REPL) on FDA Approval, Price Target Raised to $19 - GuruFocusGuruFocus · Fri, 07 Aug 2026 11:58:00 GMTXenon Pharmaceuticals Inc (XENE) (Q2 2026) Earnings Call Highlig - GuruFocusGuruFocus · Fri, 07 Aug 2026 05:02:29 GMTZTS Looks 61.9% Undervalued on GF Value™ Amid Strong Dividend Fu - GuruFocusGuruFocus · Thu, 06 Aug 2026 13:14:09 GMTIs Zoetis Inc (ZTS) Undervalued After Q2 Earnings Beat? EPS of $1.87 Exceeds Estimates; GF Score: 72/100 - GuruFocusGuruFocus · Thu, 06 Aug 2026 12:00:43 GMTBlackRock, Inc. Buys Zoetis Inc (ZTS) -- Shares Look 62% Underva - GuruFocusGuruFocus · Thu, 06 Aug 2026 04:40:24 GMT